Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03593720 · ClinicalTrials.gov registry record
Glans Size in Hypospadias Compared to Normal
A clinical trial, sponsored by Albany Medical College.
- Completed
- Registry status
- 410
- Enrollment target
NCT03593720: Completed study, sponsored by Albany Medical College.
NCT03593720 is a clinical trial that has completed, run by Albany Medical College. The registered enrollment target is 410 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03593720 has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- 410 participants
- Enrollment target
Study Summary
The investigator will collect data on penile and glans size by age, weight and ethnicity in both patients undergoing routine urological surgery and hypospadias surgery.
Primary Outcome
The investigator will prospectively collect data on glans size by age, weight and ethnicity in both patients undergoing routine urological surgery and hypospadias surgery
Interventions
- PROCEDURE Measurement in Office
- PROCEDURE Measurement in OR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2018-07-25 |
| Est. Completion | 2024-12-29 |
What the finished NCT03593720 record still lists
NCT03593720 is an observational study that tracks outcomes without assigning an intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Measurement in Office is the first listed.
NCT03593720 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03593720 about?
NCT03593720 is a clinical study titled "Glans Size in Hypospadias Compared to Normal". The investigator will collect data on penile and glans size by age, weight and ethnicity in both patients undergoing routine urological surgery and hypospadias surgery.
What is the current status of trial NCT03593720?
This trial is currently completed. The enrollment target is 410 participants. The study started on 2018-07-25. Estimated completion is 2024-12-29.
What interventions are being tested in trial NCT03593720?
The interventions under investigation include: Measurement in Office (PROCEDURE), Measurement in OR (PROCEDURE).
Who is sponsoring clinical trial NCT03593720?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI